Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects

As of 2026-06-24, the Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Last verified: 2026-06-24

Am I eligible for the Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects?

Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug's risks but downplayed them to doctors and patients.

How do I join the Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects?

1. Run the free 1-minute eligibility self-check.
2. If you qualify, register your claim on the platform.
3. Class members typically pay nothing unless money is recovered.

Other active class actions

• Inferior Vena Cava IVC Filter Class Action
• Johnson and Johnson Ovarian Cancer Class Action
• 911 Fees Class Action
• Barrick Pascua-Lama Class Action
• Bernzomatic Gas Torch Defect Class Action
• Canadian Standards Association/Standards Council of Canada Class Actio
• Chevy & Cadillac Defective Transmissions – GM Class Action Canada
• Chrysler Ignition Class Action
• Dodge Chrysler Tire Sensor Defect Class Action
• Eliquis Class Action
• Essure Permanent Birth Control Class Action
• Fiat Chrysler Diesel Emissions Class Action

← Browse all 3196+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.